Effects of Hui Medicine Aikang Fang for Lewis Lung Carcinoma Inhibition and Mutant P53 Expression

MA Ke,MA Zhi-guo,ZHANG Li-na,ZHOU Li-ping,BIAN Jing,ZHOU Hui
2012-01-01
Abstract:Objective:To observe the Hui medicine Aikang Fang's(HAF) effects on tumor growth in mice and changes of mutant p53(mtp53) expression.Method:55 normal C57 mice were inoculated with Lewis lung cancer cells.After 24h,the mice were randomly divided into model group,chemotherapy group,the low-dose group,the low-dose with chemotherapy and high-dose with chemotherapy group.After treatment,the spleen,thymus and tumor mass of all rats were tested.Expressions of mtp53 in all groups had a significantly different using immunohistochemical method.Result:① In addition to chemotherapy group,the difference between the rest groups and model group was significant in body weight(P0.05);②Inhibition rate of high-dose group was 71%.Compared with tumor-bearing model group,the difference of tumor weight in all groups were significant(P0.05);③Mtp53 expression rate of high-dose with chemotherapy group was 36.36%.Compared with tumor-bearing model group,HAF high-dose with chemotherapy group was significantly different(P0.01);④Compared with the chemotherapy group,spleen index and thymus index differences of the rest group mice were statistically significant(P0.01).Conclusion:Inhibition of HAF with chemotherapy and effects of reducing the expression of mtp53 were better than chemotherapy alone,and HAF could reduce immune suppression after chemotherapy,it may be a new target of treatment cancer.
What problem does this paper attempt to address?